Drug facts

Semaglutide, surgery and sedation

Quick answer

Tell whoever is doing the procedure that you are taking it. That is the label’s only actual instruction. It reports rare cases of pulmonary aspiration under general anesthesia or deep sedation in people who had fasted as told — and then says the available data are insufficient to recommend what to do about it.

What the label reports1

Semaglutide delays gastric emptying. The consequence the label singles out is that there have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgery or procedures requiring general anesthesia or deep sedation, who had residual gastric contents despite reported adherence to preoperative fasting recommendations.

That last clause is the whole point. The usual protection against aspiration is an empty stomach, and the ordinary fast is what is supposed to produce one.

What it declines to recommend1

The label is unusually explicit about the limits of its own advice: available data are insufficient to inform recommendations to mitigate the risk, including whether modifying preoperative fasting or temporarily discontinuing the drug would reduce retained gastric contents.

So the two things a reader most wants to know — fast for longer? stop beforehand, and for how long? — are exactly the two the label says it cannot answer. Any page that answers them confidently is not reading this one.

The one instruction it does give1

Instruct patients to inform their healthcare providers before any planned surgery or procedure that they are taking it. That is actionable, it is the whole instruction, and it puts the decision with the anesthetist, who can weigh it against everything else about the case.

It applies equally to a compounded vial. The delayed gastric emptying is a property of the molecule — the same one behind constipation — not of who packaged it.

What this page is not

This is not perioperative advice and cannot be. It reports section 5.10 and stops where the label stops.

Sources

  1. FDA prescribing information for WEGOVY (semaglutide), section 5.10 Pulmonary Aspiration During General Anesthesia or Deep Sedation, revision 6/2026 DailyMed
  2. FDA prescribing information for WEGOVY (semaglutide), section 12.2 Pharmacodynamics, revision 6/2026 DailyMed